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PREOPERATIVE, INTRAOPERATIVE, AND POSTOPERATIVE PLANNING 




Following the publishing of the Management of Myelomeningocele Study, 
the advantages of in utero repair for fetal myelomeningoceles became points of 
interest for fetal surgeons. There are many variables that must align in order to 
have success in this type of repair. When a patient is eligible for this prenatal 
procedure it is preferable to perform it rather than do the repair postnatally as 
neurological outcomes for the infant tend to be much better following earlier 
intervention. It is very important to have a clear preoperative plan before 
beginning any fetal surgery. In doing so, one limits unforeseen events that may 
arise. With this in mind, we chose to analyze factors that affect the rates of patch 
placement (in lieu of a primary skin closure) during the prenatal repair and rates 
of shunt placement after the infant is born.   
A retrospective study was conducted on patients who underwent in utero 
repair for a myelomeningocele or myeloschisis defect at the Colorado Fetal Care 
Center. Multivariate analyses were performed to identify which preoperative, 
intraoperative, and postoperative factors were statistically significant (p ≤ 0.05) in 
predicting patch and shunt placement.  
 
 vi 
Neuroimaging was found to be a key tool in predicting patch and shunt 
placement. Additionally, gestational age during prenatal intervention was found to 
be predictive of patch placement while the preoperative degree of cerebellar 
descent relative to the foramen magnum as well as 2-week hindbrain herniation 
classification were found to be predictive of shunt placement.  
These crucial findings will give physicians a framework to use when 
creating their preoperative plans and in doing so will allow for higher chances of 
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Spina bifida is a congenital neurological defect that affects the proper 
closure of the caudal neural tube during gestation [4]. This occurs when there is 
a failure in the signaling of the neural tissue in the mesoderm and ectoderm 
(Figure 1). This leads to abnormal bony structures atop the maldeveloped neural 
tube (Figure 2) [21].   
 
 
Figure 1: Fetal Embryology of an MMC. Ventral view of a fetus at 33 weeks 
gestation with a lumbosacral MMC. Arrows indicate the areas of periventricular 
heterotopias [7]. 
 
There are different types of open neural tube defects that may arise 
following this failure in development including encephalocele, anencephaly, 
meningocele, myelomeningocele, and myeloschisis. Development of an 
encephalocele or anencephaly is attributed to the inability of the proximal end of 
the neural tube to fuse [21]. The remaining types of neural tube defects affect the 
development of the meninges and/or the spinal cord. A meningocele occurs 
when a sac is formed with inclusions of the meninges but the spinal cord itself is 
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not affected. When the spinal cord is also involved in the distorted meningeal 
sac, the abnormality is called a myelomeningocele (MMC) [19]. Relevant defects 
have been further detailed in Figure 3. 
  
 
 Figure 2: Fetus with Spina Bifida. A fetus at 16-weeks gestation suffering from 
spina bifida. The grey arrow is indicating the caudal neural tube. The arrowheads 
indicate the neural plate. The full arrows indicate the malformed skin around the 
defect [7].  
The MMC is the most common type of spina bifida affecting every “3.4 per 
10,000” liveborn infants within the United States [3]. When the defect is much 
more involved and there is no membrane covering the open nervous tissue, the 




Figure 3: Characteristics of the Types of Spina Bifida. Asterisks (*) indicate the 
types which are highlighted in this paper [19].  
 
The focus of this paper will be on the last two conditions described, MMC 
(Figure 4) and myeloschisis (Figure 5).  
 
Figure 4: Unresolved MMC with Cystic Sac Intact. This sac contains both the 




Figure 5: Unresolved Myeloschisis. Note the lack of a cystic component [12]. 
 
Patients suffering from either of these conditions must face a lifelong 
battle with neurologic deficits regardless of any surgical intervention. These can 
affect varying parts of the body including mental deficiencies, trouble controlling 
bladder or bowels, and motor dysfunction (Table 1) [2].  
 
Table 1: Possible complications due to MMC or myeloschisis [18]. 
Abnormal Sensation/Paralysis  Leg and/or core weakness/paralysis 
due to nerve damage. The lower the 
spinal level of the defect the less 
significant the neurological deficits. 
Can be asymmetric. 
Bowel/Bladder Incontinence Since the nerves at the bottom of the 
spinal cord control bowel/bladder 
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function almost all spina bifida 
patients experience incontinence.  
Hydrocephalus  A buildup of CSF that puts damaging 
pressure on the brain. Can be 
alleviated with shunt placement. 
Chiari II Malformation  Herniation of the brainstem structures 
and the cerebellum (hindbrain) 
through to spinal cord. It puts pressure 
on the cord leading to upper limb 
weakness and difficulty with breathing 
and swallowing.  
Tethered Cord Syndrome Normally the spinal cord and 
associated nerves are free to float. 
When tethered some tissue is 
attached to the cord and pulls it down. 
This causes nerve damage which 
leads to weakness as well as 
bowel/bladder incontinence.  
Meningitis   Infection that leads to inflammation of 
the meninges. Can be caused by 
shunt infection.  
 
 6 
Reduced Cognitive Function  Neurologic deficits including problems 
with attention, memory, 
organization/problem solving skills, 
and motor function.  
Others  Impaired function involving bone 
mineral density, male fertility, renal 
function, sleep. Can also lead to 




There are multiple variables that have been identified as risk factors for 
developing an open neural tube defect. Folic acid intake is among one of the 
most implicated. Since the 1980’s, folic acid supplementation has been a widely 
accepted means of decreasing the risk of open neural tube defects [21]. Folate is 
an important factor in metabolic pathways in the body. One such pathway is for 
the synthesis of nucleic acids while the other is for methylation reactions [16]. 
Both of these pathways are vital in the development of an embryo. Some animal 
models show that a disruption in folate metabolism may lead to an unfavorable 
buildup of homocysteine concentration in the body which becomes a teratogen 
for the developing fetus [16]. Women who are planning on conceiving are 
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advised to take at least 0.4 mg of folic acid per day in order to decrease the 
chance that their fetus may develop an open neural tube defect [21]. 
Family history is another strong risk factor. Having a sibling with an open 
neural tube defect can raise the risk of a subsequent child developing the defect 
anywhere from 3% to 8% [16]. The majority of spina bifida cases are sporadic in 
nature but there have been some genetic precursors associated with it [21]. 
These genetic variants may affect either the maternal genotype or the fetal 
genotype. Genetic mutations that target any of the folate pathways in the body 
will in turn increase the risk of developing the defect. Additionally, interactions 
between different folate pathway genes and with folate pathway genes and 
environmental factors have also been implicated in the etiology of spina bifida 
[16].  
A different mechanism through which a fetus can develop spina bifida is 
via additive defects. In other words, a genetic mutation for one defect may 
increase the chances of the fetus also developing an open neural tube defect. 
Genetic disorders that have been associated with open neural tube defects 
include trisomy 18, Lehman syndrome (autosomal dominant), Meckel-Gruber 
syndrome (autosomal recessive), VATER syndrome (autosomal recessive), 
Mathias laterality sequence (X-linked), and other X-linked neural tube defects 
[21]. 
Maternal diabetes and obesity have been identified as possible risk factors 
as well. More specifically, women who suffer from pregestational diabetes are at 
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anywhere from 2 to 10 times more likely to develop a fetus with some type of 
central nervous system defect, under which spina bifida falls [16]. Higher 
maternal glucose concentrations have been proposed to be associated with the 
incidence of fetal spina bifida. However, it is unclear whether the glycosylated 
hemoglobin concentrations are directly affecting the fetus’s development or if 
they are an indicator of another teratogenic factor. Being overweight with an 
increased body mass index (BMI) greater than 29 kg/m2 is associated with a 1.5 
to 3.5 higher risk of a woman developing a fetus with spina bifida than a woman 
who has a lower BMI [16]. A suggested mechanism to explain these higher rates 
of incidence amongst women with pregestational diabetes and/or obesity is the 
hyperinsulinemia that results from these afflictions [16]. 
Various drugs have been associated with increased occurrence of fetal 
MMC. Anticonvulsants have been the best recognized as increasing risk of 
development. Some well-known drugs that have these effects are valproic acid 
and carbamazepine [16]. The risk can be increased by up to 1% to 2% when the 
mother is taking these drugs because during pregnancy it is hard for some 
patients to come off these given that their purpose is to manage epilepsy. The 
precise mechanism through which these anticonvulsants affect the fetus is 
unclear. One proposed mechanism is that free radicals formed through the drug’s 
metabolism can be damaging to the fetal tissue. Another suggested mechanism 
is that they act as antagonists in folate metabolism. As previously stated, any 
disruption in folate metabolism can be detrimental in fetal development [16]. 
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Conclusive studies have not yet been done to see if additional folate 
supplementation could diminish the risk of MMC development in people who take 
anticonvulsants.  
Environmental factors are always a concern during pregnancy. Some 
environmental factors have been identified as potential risk factors however none 
of them have been clearly proven. Chlorination, pesticides, hazardous waste, 
and electromagnetic fields have all been found to be associated with open neural 
tube defect development [16].  
An interesting factor that can come into play is maternal diarrhea. The loss 
of nutrients that can occur with severe and frequent diarrhea affects the nutrients 
that are available to the fetus. This lack in nutrients can hinder fetal development 
[16]. Additionally, maternal hyperthermia can have adverse effects on fetal neural 
tube development. This can occur secondary to fever or can even be brought on 
by outside sources such as hot tubs and electric blankets [21].  
 
Diagnosis 
When diagnosing either an MMC or myeloschisis, lab tests as well as 
neuroimaging must be done. Maternal serum alpha-fetoprotein is one indicator of 
an open neural tube defect. Following the detection of maternal serum alpha-
fetoprotein, an amniocentesis can determine the concentrations of alpha-
fetoprotein and acetylcholinesterase. These concentrations can differentiate 
between an open neural tube defect or open ventral wall defects [16]. An 
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ultrasound can then confirm the proper diagnosis (Figure 6) followed by magnetic 
resonance imaging (MRI) scans which provide further clarity of the severity of the 
defect.  
 
Figure 6: Ultrasound of a Fetal MMC. This image was taken in the transverse 
plane of the spine at a gestational age (GA) of 22 weeks. The left image shows 
the laminae which are still intact. The center image indicates the MMC sac with 
the straight arrow while showing the posterior separation with curved arrows both 
of which are situated below the aortic bifurcation. The arrows in the right image 
indicate the same at the level of the iliac crests [1]. 
 
During the ultrasound the physician is able to check for “spontaneous leg 
and foot movement”, the absence of such movement can indicate a highly 
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involved defect. The ultrasound can also detect if there is a Chiari II 
malformation. This malformation is very common in fetuses with an MMC or 
myeloschisis. Almost all fetuses with these diagnoses exhibit a Chiari II 
malformation. The malformation allows the cerebellum and parts of the brain 
stem to herniate through the foramen magnum at the base of the skull. This can 
have severely negative effects on the child. Untreated, a Chiari II malformation 
can result in oscillopsia, hemi- or quadri- paresis, nystagmus, and opisthonos [5]. 
Studies have shown that surgical decompression can alleviate these symptoms 
in older children and adults experiencing a Chiari II malformation. However, 
infants are not as responsive to surgical decompression. Here lies the debate on 
whether prenatal or postnatal surgical repair is more advantageous to the fetus.  
 
Surgical Repair 
Traditionally postnatal repair was the common standard of practice. The 
idea of prenatal repair was introduced to overcome the “two-hit hypothesis”. This 
hypothesis explains the 2 events during gestation that increase injury to the 
fetus. The primary event is the actual development of the abnormality where the 
fetal neural tube fails to close properly leading to an MMC or myeloschisis. The 
second event in the two-hit hypothesis is the damage that occurs to the fetus 
through both mechanical and chemical injury from residing in the mother’s 
uterus. The uterine environment can have detrimental effects on an open neural 
tube defect. It is more susceptible to mechanical injury if the mother were to 
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experience any physical trauma during her pregnancy. Mechanical injury can 
also occur through the hydrodynamic pressure in the uterus. Chemical injury can 
occur via exposure of the fetal neural tissue to amniotic fluid. Earlier intervention 
can prevent or lessen these detrimental effects to the fetus by allowing for some 
protection to the spinal cord before birth. While in utero repair will not prevent the 
damage done by the primary factor, it can reduce the damage inflicted by 
potential secondary factors [2].  
The detection of an MMC or myeloschisis can occur earlier than 20 weeks 
gestation making the fetus a candidate for in utero repair. This early intervention 
can also lessen the neurological deficits that the fetus must endure. 
Neuroimaging based case studies have shown that a fetus can have 
spontaneous leg movements and other motor abilities present between 17- and 
20- weeks gestation followed by a loss in these motor functions due to 
progressive deterioration of the neural tissue. By performing in utero repair of the 
defects, one can avoid more severe negative outcomes for the infant [16]. The 
first attempt at in utero repair was done endoscopically. This method was a valid 
first method to try. The idea behind an endoscopic approach presumably was to 
be as minimally invasive as possible to reduce the degree of risk to both the 
mother and fetus. However, this approach proved to be unsuccessful. Performing 
the repair through a hysterotomy is now the common surgical method for in utero 
repairs of an MMC or myeloschisis (Figure 7) [16]. After performing the 
hysterotomy, the fetus is positioned in order to expose the spinal defect and is 
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held in place by a member of the surgical team. They must be cautious not to 
apply excessive pressure to the fetus to avoid any bradycardic events. The fetus 
is then administered a muscle relaxant – a narcotic mixture to enhance the 
anesthetic effects. Once the surgeon gets to the fascial layer, they must then 
excise any epithelialized skin from the placode. In doing so, the placode is 
released from the meningeal sac. Any leftover epithelial tissue can put the fetus 
in danger of developing an epidermoid/dermoid inclusion cyst. Attempts at re-
neurulation of the placode are not performed since there is too high of a risk of 
causing further neural trauma which in turn could lead to increased neurologic 
deficits. Following this, the surgeon prepares for closure. The dura is connected 
laterally to the fascial layer. If this closure needs some extra strength then a dural 
substitute is added. Myofascial closures may be necessary if the defect is too 




Figure 7: Principal Steps for In Utero Repair of Fetal MMC. (A) Positioning of 
fetus to prepare for the repair. (B) Hysterotomy step to reveal fetal defect. (C) 
Closure of defect [3]. 
 
Due to the fragility of fetal skin, a patch may be needed to sufficiently 
close a defect that covers a larger surface area of the skin [11]. Alloderm is a 
commonly used patch. It is an acellular partial thickness human dermis that 
allows for rapid revascularization and tissue integration [23]. In addition to the 
aforementioned advantages to prenatal repair, through the Management of 
Myelomeningocele Study (MOMS), it was found that infants who had undergone 
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prenatal repair of their defect had a decreased need for a ventriculoperitoneal 
(VP) shunt and had better mental and motor function when compared to patients 
that had undergone postnatal repairs. In the prenatal group, the degree of 
hindbrain herniation (HBH) was better improved and also had a better chance of 
independent ambulation [3]. 
Expectedly, there were some disadvantages to prenatal surgery when 
compared to postnatal surgery. Prenatal intervention was associated with an 
increased risk of premature birth and surgical complications. On average, infants 
born after prenatal surgery for MMC repair were born 3 weeks sooner than 
patients in the postnatal repair group [24]. Some notable complications include 
respiratory distress, apnea, necrotizing enterocolitis, and chorioamniotic 
separation. 
Chorioamniotic separation can lead to spontaneous membrane rupture 
which in turn results in preterm labor. This can be a dangerous outcome due to 
the fact that a caesarean section prior to the onset of labor is advised for patients 
upon whom in utero surgery was performed [3]. This is to minimize any additional 
trauma to the fetus during labor. This procedure puts the mother at risk for 
uterine dehiscence and preterm rupture of membranes so mothers are advised to 
plan to have a caesarean section prior to the onset of labor for any subsequent 
pregnancies as well [3]. Although these factors can put both the mother and fetus 
at risk, one must weigh the advantages against the disadvantages of prenatal 
repair. Given the significant improvement in neurologic outcome and finer quality 
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of life following in utero repairs, patients that qualify for the procedure should 
strongly consider prenatal surgery for fetal MMC or myeloschisis. It is also 
important to understand that even with the potentially better outcomes for fetuses 
that undergo prenatal repairs, any infant afflicted with an MMC or myeloschisis 
regardless of the type of repair they have, will face a lifetime of complications 
because any damage done by the defect is rarely reversible.  
Being a lifelong disorder, another variable to consider is cost. In a 2012 
study, it was estimated that for every 100 patients, prenatal repairs would save 
$2,066,778. Given the variability in cost, depending on where each patient is 
receiving care, prenatal intervention of an MMC was found to be cost effective at 
least 65% of the time and cost saving 52% of the time [24].  
As previously mentioned, there is sometimes a need for a patch repair 
when a primary closure is not possible. This can happen if the defect is too large 
for a primary skin closure or if the fetal skin is too fragile to suture back together 
in which case the Alloderm graft provides extra support. The Alloderm patch is 
harvested human cadaver skin that is processed to excise the epidermis and 
dermal cells while maintaining the extracellular matrix as well as the basement 
membrane. This allows the patch to diminish the risk of rejection by the host 
while preserving structural integrity. The structure of the Alloderm patch makes it 
easy for the host cells to infiltrate and permit neovascularization and repopulation 
of fibroblasts. The reduction in the risk of an inflammatory response upon 
placement of an Alloderm patch is due to its lack of non-host cells. While an 
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immunologic reaction after placing any sort of patch can be a significant concern, 
the technology behind the Alloderm patch has mitigated these concerns and is 
regularly used in procedures such as in utero repairs of an MMC or myeloschisis 
[23]. However, in either case, primary closure or closure with the aid of a patch, 
creating as watertight of a closure as possible is crucial to preventing ongoing 
cerebrospinal fluid (CSF) leakage.  
A primary closure is preferred as it is more likely to be watertight. 
However, with the fragility of fetal skin or with larger defect surface areas, it is 
hard to close with the fetal skin alone. The issue that arises with using the patch 
repair method is that there is a higher chance of CSF leakage through the area of 
the repair. Patch material is porous to allow host cell infiltration. With this porosity 
comes the potential for CSF leakage which would lead to further complications 
and the need to place a VP shunt after birth.  
Placement of a VP shunt is not only correlated with patch placement, 
however. There are a multitude of factors that play into shunt placement. This 
need arises when the infant presents with hydrocephalus. Hydrocephalus is a 
very common ailment that newborns face. It is due to either an overproduction of 
CSF or from an obstruction to CSF flow. Patients with an MMC or myeloschisis 
diagnosis experience hydrocephalus due to structural defects such as an 
obstruction in the 3rd or 4th ventricle, abnormal venous compliance, and/or 
arachnoid or ependymal scarring. Regardless, the buildup of fluid in the 
ventricles causes ventriculomegaly and in turn results in abnormally increased 
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intracranial pressure. This increased pressure put cranial structures in danger of 
damage and can lead to variable neurologic symptoms. If the pressure is not 
relieved, this can lead to secondary effects such as neurovascular damage 
coupled with inflammation. These effects can increase susceptibility to tissue 
damage and result in hindered brain development in the infant. When the 
pressure is relieved by use of a shunt in a timely manner, these effects may 
reverse. 
The first attempts to alleviate the intracranial pressure due to CSF were 
through the use of either an open craniotomy or endoscopically. Both of these 
methods proved to be unsuccessful and had high morbidity and mortality rates. 
The introduction of shunt placement to remove the intracranial pressure has now 
become the standard approach. There are a few different types of shunting 
methods. The main goal is to divert the CSF from the ventricles to another area 
of the body to then be absorbed. The most common type of shunt used in spina 
bifida cases is the VP shunt. This diverts the CSF from the ventricles to the 
peritoneal cavity in the abdomen. Shunts consist of silastic tubing which are 
made from silicone. In the instance of VP shunts, the tubing runs subcutaneously 
from the ventricles in the brain to the peritoneal cavity (Figure 8). A valve lies 
between the proximal and distal catheters which regulates flow of fluid. 
Antisiphon/gravitational devices are paired with the valve in order to regulate the 
CSF drainage. Without these mechanisms in play, one runs the risk of over 
draining the CSF and severely decreasing the intracranial pressure.  
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As with the placement of any medical device, there are always risks and 
complications. Around 40% of patients tend to have the need for a shunt revision 
within the first 2 years of placement due to a mechanical obstruction causing the 
shunt to fail. A return of symptoms that the patient was experiencing prior to 
shunt placement is indicative of shunt failure. Mortality with shunt placement is 
only 0.5%. Other complications that could occur at any time and necessitate the 
need for shunt revision include infections usually within the first few months and 
obstruction [14]. If the shunt malfunctions and over drainage does occur, the 
patient may present with a hygroma (low oncotic pressure CSF collection in the 
subdural space) or a hematoma (blood collected outside of the vasculature) [9].  
 




All of the aforementioned factors have their own roles to play in the 
process of diagnosing and treating patients that develop an MMC or 
myeloschisis. Due to the complexity these defects, it is very important to have as 
clear of a preoperative plan as possible. This is especially vital for cases that 
involve in utero repair of the defect. Key measures that can be taken into 
consideration prior to surgery are through neuroimaging. In the past, both 
ultrasound and MRI scans have shown to be complementary to one another. 
They allow the surgical team to take measurements such as ventricular size, 
defect length, defect width, and defect surface area. Additionally, they can use 
other patient characteristics and surgical descriptors to help them create the best 
plan of action for the patient. While it is important to follow a standardized 
approach for in utero repair, there are always certain parts that must be 
individualized to each patient. This is why it is vital that the “standard” be 
somewhat customizable to each individual patient. 
Each patient is going to have variable needs based on factors such as GA 
at the time of the procedure or degree of HBH (both before and after surgery). 
We therefore postulated that neuroimaging as well as other preoperative 
measures may provide the surgical team with a plan before each procedure with 
regards to the need for patch placement during surgery. In the same vein, 
preoperative neuroimaging and classification of HBH at 2 weeks of age may 
predict the need for the placement of a VP shunt. It is crucial to have an idea of 
what to expect going into surgery and throughout the months following the 
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operation. There are always going to be unknowns with cases such as these. 
Being able to use preoperative, intraoperative, and postoperative factors to 





























The goal of this paper was to perform a retrospective study on prospective 
cases of in utero repairs of fetuses presenting with an MMC or myeloschisis. Our 
study was in line with the monumental MOMS trial that shed light on the 
advantages of prenatal intervention for these kinds of defects rather than the 
older method of postnatal repair. Through this study we examined the rates of 
patch placement during surgery and what preoperative factors may be predictive 
of the need for a patch repair. We also analyzed preoperative, intraoperative, and 
postoperative factors that may be predictive of shunt placement after birth of the 
infant. These analyses were done in order to help standardize the way 
physicians create a preoperative plan for each patient based on their unique 














IRB Approval  
To test our hypotheses a protocol was developed to standardize 
preoperative planning, intraoperative repair, and postoperative follow-up. A 
retrospective study was conducted on the closure type in all fetal repairs of MMC 
or myeloschisis at the Colorado Fetal Care Center between 2013-2020 where a 
total of 85 patients were seen and analyzed. This retrospective review and 
prospective data collection in our MMC database were approved by the 
University of Colorado Institutional Review Board (13-3013).  
 
Preoperative Planning, Standardized Testing, and Preoperative/Postoperative 
Protocols 
 Patients underwent a series of consultations by the whole surgical team. 
This team involved the following departments: Maternal-Fetal Medicine, Fetal 
Surgery, Radiology, Genetics, and Neurosurgery. Each of these departments 
played a crucial role in the process. Maternal-fetal medicine, also known as 
perinatology, is a specialty that branches from obstetrics. These types of 
specialists are trained to deal with high-risk pregnancies. Not only were they 
concerned with managing the health of the fetus but also with making sure the 
mother is safe and healthy. A high-risk pregnancy could be any pregnancy that 
puts the life of the mother or fetus in danger. Many factors constituted a high-risk 
pregnancy. Some of these factors included gestational diabetes, preexisting 
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diabetes, preeclampsia, preexisting heart conditions, multiple pregnancies, and 
the fetus’s development of any type of condition (including but not limited to MMC 
and myeloschisis). These complications are detailed in Table 2. 
Table 2: Factors of High-Risk Pregnancy [20]. 
Gestational Diabetes (most 
common pregnancy complication) 
Pregnant women have increased 
insulin resistance. When their 
pancreatic beta cells cannot replenish 
insulin sufficiently, they experience 
symptoms similar to type II diabetes. 
Preexisting Diabetes Preconception hyperglycemia is 
associated with development of 
congenital anomalies.  
Preeclampsia Gestational hypertension with 
proteinuria. Causes high blood 
pressure and signs of damage to other 
organ systems. Increases rates of: 
perinatal death, preterm delivery, and 
maternal death. 
Preexisting Heart Conditions 
(causes disproportionately high 
number of maternal deaths in USA) 
Pregnancy puts strain on cardiac 
function. Preexisting cardiac issues 
are exacerbated during pregnancy. 
Leads to increased: intravascular 
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volume, cardiac output, coagulability. 
Decreased: vascular resistance. 
These can cause reduced 
hemoglobin/hematocrit as well as a 
thrombophilic state.  
Multiple Pregnancies Most at risk for preterm delivery.  
Can also cause: preeclampsia, 
preterm rupture of membranes, low 
birth weight, and neurologic deficits. 
Abnormal Fetal Conditions  Condition (such as MMC and 
myelomeningocele) put both mother 
and child at risk for preeclampsia, 
preterm labor, etc. 
 
Fetal surgery is a branch of maternal-fetal medicine. Fetal surgeons have 
specialized training that allows them to perform open fetal surgery which is how 
the in utero repairs were done in this study. Open fetal surgery was done by first 
putting the mother under general anesthesia which relaxed the uterus while still 
allowing oxygen to reach the fetus through the placenta. This exchange of 
oxygen through the placenta was also the same way that some of the anesthesia 
reaches the fetus so that no pain was felt. Fetal surgeons would not be able to 
make such advancements in medicine without the neuroimaging done by the 
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radiology team. The radiologist provided the ultrasound and MRI scans from 
which a preoperative plan is made by taking measurements of the defect. They 
were also used to later monitor the infant’s progress. The medical geneticist was 
able to provide counseling and advisement for the parents as this is a rather 
complicated and difficult disorder to manage. The rest of the neurosurgical team 
supported the fetal surgeon in cases of MMC and myeloschisis as this directly 
affected the spinal cord and brain function [8].  
Neuroimaging was performed to acquire preoperative measurements and 
determine other growth markers such as number of spinal levels affected, 
preoperative grading, and differentiating between MMC and myeloschisis. Fetal 
ultrasound scans were taken to measure ventricular dimensions. Fetal MRI 
scans were taken to both measure ventricular size and the degree of HBH. All 
MRI scans were performed on a 1.5T scanner with a body coil. A 3D T2-
weighted Turbo Spin-Echo sequence (TR = 1900 ms; TE = 110 ms; section 
thickness = 1.0 mm; field of view = 300 mm; matrix = 200x154 reconstructed 
voxel size 1.5 mm x 1.5 mm x 1.5 mm) was performed in both axial and sagittal 
planes to the spinal defect. During the procedure, patients were under 
continuous cardiac fetal monitoring by a pediatric cardiologist. Additionally, there 
were intraoperative contributions from maternal-fetal medicine, fetal surgery, and 
neurosurgery.  
 Postoperatively, patients were admitted to the maternal-fetal medicine 
service. Postoperative serial ultrasound scans were conducted daily to evaluate 
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cervical length as well as monitor the potential need for a cerclage. The cerclage 
procedure required the physician to place a suture around the cervix in order to 
prevent preterm labor. Ultrasound scans to measure cervical length indicated 
whether a woman was in need of a cerclage (Figure 9) [22].  
 
Figure 9: Ultrasound of Short Cervix Qualifying for Cerclage [10]. 
 
Often, patients were administered a magnesium drip or indomethacin. 
Both the magnesium drip and indomethacin were used to prevent preterm labor. 
The magnesium drip was first used to prevent seizures in women experiencing 
preeclampsia. When physicians saw how it reduced contractions in preeclamptic 
women, they then started to administer it to women who were showing signs of 
preterm labor. The magnesium drip has been shown to postpone preterm labor 
by at least 48 hours and has very minimal adverse effects [17]. Indomethacin is 
also known to delay preterm labor for at least 24 to 48 hours [15]. Most patients 
were discharged on postoperative day (POD) 3 to 6. Depending on the physical 
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location of the patients and the need to deliver at a specialty center, 
arrangements were made to deliver at Children’s Hospital Colorado (CHCO) or 
near the patient’s home. 
 After 2 weeks of age, infants underwent repeat neuroimaging scans 
including both ultrasound and MRI scans. The degree of HBH was determined 
through these scans on a scale of 0 to 3 (Table 3). The appearance and 
resolution of HBH is illustrated in Figure 10.  
Table 3: Classification of Hindbrain Herniation  






Figure 10: Hindbrain Herniation in a Lamb. (A) Appearance of hindbrain 
herniation in a lamb. (B) Lack of hindbrain herniation in a lamb that underwent 




 Repairs were either closed via a primary skin closure or with the use of a 
patch. A primary skin closure was preferred as it is much easier to obtain a 
watertight closure. However, some cases necessitated a supplemented closure. 
Instances where extra steps were taken to properly close the defect were when 
the defect was too large or the fetal skin was too fragile to safely close with the 
skin alone. These repairs were referred to as patch repairs. Patch repairs were 
done with commercially available collagen matrix as a dural substitute and an 
acellular human dermis (Alloderm) in place of skin closure. A myofascial closure 





Figure 11: Principal Steps for MMC repair with a Myofascial Closure. (a) 
Stabilizing the fetus. (b) Incision around the MMC. (c) Dissecting the arachnoid 
and epithelial tissue from the neural placode. (d) Lateral myofascial layer 
incisions followed by medial rotation to reduce tension and allow mobilization of 
the skin during wound closure. (e) Closing the myofascial layer. (f) Completing 







SPSS and Prism statistical programs were used in order to calculate the 
significant values for this study. Multivariate analyses using logistic regression 
were conducted to investigate the association between surgical factors and their 
ability to predict patch and ventriculoperitoneal shunt placement. Factors tested 
were considered statistically significant when they displayed a p value less than 




















 The breakdown of patient diagnoses has been categorized in Figure 12. 
The average age of fetal intervention was 24.18 weeks and average GA at time 
of delivery was 29.86 weeks. All patients had a preoperative HBH grades of 3. 
 
Figure 12:  Breakdown of Patient Diagnosis and Repair Mechanism. 
  
Of the 85 patients, the defect diagnosis of 43 (51%) patients was MMC 
and 42 (49%) patients was myeloschisis. A patch repair was performed in 18 
(42%) of MMC patients versus 24 (57%) of Myeloschisis patients. The predictive 
power of patch placement based on defect diagnosis was not significant (p= 
0.160). Additional patient characteristics that were relevant to prenatal 




Table 4: Additional Patient Characteristics  
Average Maternal BMI 27.51 kg/m2 
Average Maternal Age at Time of 
Evaluation  
28.02 years  
Average Gestational Age at Time of 
Evaluation 
23.14 weeks  
Average Gravida  2 
Average Para 1 
 
Surgical Descriptors 
 Table 5 features variables that were measured during the procedure for 
each patient. Averages were calculated and spilt based on patch placement. 
Other surgical descriptors included type of incision and intraoperative events. 
The types of incisions are detailed in Table 6. The majority of patients did not 
experience any negative intraoperative events. Some notable intraoperative 
events included bradycardia and chorioamniotic separation. There were 3 cases 
of maternal bradycardia. The first was treated with atropine. The second was 
treated with a combination of atropine and terbutaline. The third occurred during 
the hysterotomy and was treated by decreasing the amount of inhalation agent 
being administered. 3 cases of fetal bradycardia occurred as well. 2 of these 
cases lasted less than 1 minute and proceeded to resolve on their own. The third 
case of fetal bradycardia was treated with a combination of epinephrine and 
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atropine. The last intraoperative event that took place was a chorioamniotic 
separation which as previously described can put the patient at risk for premature 
rupture of membranes and can increase the chance of a dangerous delivery.  
  
Table 5: Averages of Surgical Descriptors Split Based on Patch Placement: This 
table shows the averages for GA at time of procedure, total procedure time, 
repair time, maternal estimated blood loss (EBL), and fetal EBL. Patient data is 
categorized based on whether or not a patch was placed during the repair.   
 Patch No Patch 
GA at Time of 
Procedure 
23.94 Weeks 24.44 Weeks 
Total Procedure Time 128.6 Minutes 128.42 Minutes 
Repair Time 33.85 Minutes 28.14 Minutes  
Maternal EBL 31 mL 29 mL 
Fetal EBL 3 mL 2 mL 
Table 6: Incision Type Split Based on Patch Placement 
Incision Type Patch No Patch 
Anterior 23 21 
Posterior 16 16 
Fundal  1 4 
Anterior/Fundal 0 1 




 Measurements taken from preoperative neuroimaging using MRI scans 
were associated with correctly predicting the need for a patch during surgery. 
Scans which helped visualize ventricular size, defect length, defect surface area, 
and defect length to width ratio proved to be the most accurate patch predictors. 
Table 7 details the statistical significance associated with using preoperative MRI 
scans to predict patch placement. Another preoperative factor that proved to be 
significant was the GA at the time of the procedure. A lower GA at the time of the 
procedure was associated with the need for a patch during surgery. Other 
preoperative factors that were analyzed but did not prove to have sufficient 
statistical significance in our cohort were maternal age, ethnicity, race, BMI, 
gravida status, para status, defect diagnosis (MMC or myeloschisis), number of 
spinal levels involved in the defect, preoperative HBH grading, and preoperative 











Table 7: Patch Predictors 
Patch Predictive Factor p Value 
MRI Preoperative Left Ventricle Size  0.018 
MRI Preoperative Right Ventricle 
Size  
0.008 
GA at Time of Procedure 0.011 
MRI Defect Length  0.003 
MRI Defect Surface Area 0.002 
MRI Defect Length: Width 0.040 
 
Postoperative Results 
 MRI scans were taken at 2 weeks of age. These scans were used to 
compare ventricle size between patients that received a patch and those that did 
not. The scans also allowed comparison between preoperative ventricle size and 
postoperative ventricle size within the same patient. Patients that received a 









Table 8: 2 Week MRI Ventricle Size  
 Patch No Patch 
2 Week MRI Left 
Ventricle Size  
12.27 mm 14.56 mm 
2 Week MRI Right 
Ventricle Size  
11.61 mm 13.15 mm 
 
There were 8 patients who received a cerclage procedure postoperatively. 
Some mothers experienced complications associated with the procedure of the 
hysterotomy. 9 of these patients experienced a chorioamniotic separation. 5 
patients experienced pulmonary edema (abnormal collection of fluid in the lungs). 
1 patient experienced the opening of a fascial seroma during their cesarean 
section.   
The average GA at time of birth for patients with a patch was 30.47 weeks 
while the average GA of patients without a patch was 29.32 weeks. All patients 
were delivered via cesarean section procedures. On average the patients with a 
patch were delivered 6.53 weeks premature based on their estimated date of 
delivery. Patients without a patch were delivered 7.68 weeks premature. 







 Out of the 85 patients involved in the study, there were 72 patients for 
whom shunt data was complete. In the patients who received a patch, 17 (44%) 
needed a shunt and 22 (56%) did not need a shunt. In the patients who did not 
receive a patch, 12 (36%) needed a shunt and 21 (64%) did not need a shunt. 
Overall, a higher percentage of patients did not have a shunt placed. Out of the 
patients that did need a shunt, there were some factors that proved to be 
significant in predicting shunt placement. The significant factors are shown in 
Table 9. Factors which were analyzed but did not prove to be statistically 
significant in predicting shunt placement included: GA at time of the procedure, 
defect length, defect width, defect surface area, defect length:width ratio, defect 
diagnosis (MMC vs. myeloschisis), patch placement, total procedure time, repair 












Table 9: Shunt Predictors 
Variable p Value 
MRI Preoperative Left Ventricle Size  0.006 
MRI Preoperative Right Ventricle 
Size 
0.017 
US Preoperative Left Ventricle Size  0.046 
US Preoperative Right Ventricle 
Size 
0.020 
Preoperative Degree of Cerebellar 
Descent Relative to Foramen 
Magnum  
0.05 














The goal of this study was to identify which factors (preoperative, 
intraoperative, and postoperative) can be used to help predict the need for a 
patch repair during the in utero repair of an MMC or myeloschisis as well as the 
need for a VP shunt postoperatively.  
The results of the present study suggest that preoperative neuroimaging is 
a key predictive factor for both patch repair and shunt placement. More 
specifically, for patch placement, measurements taken from MRI scans were 
predictive of the need for a patch intraoperatively (Table 7). While MRI scans 
have better resolution than ultrasound scans and make it easier to obtain more 
accurate measurements, both imaging techniques complement one another and 
aid the physicians in created as detailed of a preoperative plan as possible. As 
such, both MRI scans and ultrasound scans should be utilized to diagnose and 
treat the condition of the fetus. Both the measurements of ventricle size and 
defect measurements (length, surface area, length: width) proved to be the most 
significant measurements.  
GA at the time of the procedure also proved to be a significant predictive 
factor (Table 7). A potential explanation for this is that due to the fragility of fetal 
skin at a younger GA the surgeon may find during the procedure that they will not 
be able to successfully close the defect without using some other means of 
support for the skin. As discussed, the added step of a myofascial closure allows 
for more support during closure so that the fetus does not experience any 
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unnecessary complications during the end of the procedure. Using this technique 
reduces the amount of tension applied to the fetal skin and therefore eases the 
conclusion of the surgery. Preferably the defect would be closed primarily but 
when the defect is too large or the fetal skin is too fragile, the surgeon may see 
the need for utilizing the patch repair technique for added support just as the 
myofascial closure added support. The primary repair mechanism is preferred as 
it allows for a more watertight closure than with a patch. 
Total procedure time was relatively the same for both patch repairs and 
primary repairs. The time taken to do the actual repair during the procedure was 
higher for the patch repairs by a little under 6 minutes. It is very unlikely that this 
extra time would have any negative impacts on the success of the procedure and 
as such it did not indicate any statistical significance when tested as a predictive 
factor for shunt placement. Average maternal and fetal EBL were well within 
normal limits and did not impair surgical outcomes.  
Ventricle measurements taken preoperatively through both MRI and 
ultrasound scans were shown to be significant predictive factors for the need of a 
VP shunt (Table 9). These measurements are key in shunt prediction. This 
further supports the necessity of using both MRI and ultrasound scans to 
effectively visualize the defect and plan for additional intervention by inserting a 
VP shunt. Preoperative degree of cerebellar descent relative to the foramen 
magnum and classification of HBH at 2 weeks of age are additional factors that 
were important in predicting the need for a VP shunt (Table 9). Studies have 
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shown that HBH is related to the continual leak of CSF through the MMC defect. 
This leakage of CSF increases the risk of HBH and hydrocephalus which leads to 
mal-development through compression of the cerebellum, brainstem, cranial 
nerves, and skull. Insertion of a shunt to redirect flow of CSF is necessary in 
these cases in order to reverse or at the very least stop the neurological damage 
inflicted by this increase in hydrostatic pressure. Resolution of HBH improves 
overall survival and reduces clinical symptoms related to posterior fossa 
compression syndrome. The vast majority of MMC and myeloschisis patients 
experience some degree of hydrocephalus. Hydrocephalus that leads to adverse 
neurologic symptoms requires the insertion of a shunt.  
Further studies should be done to evaluate if HBH in patch repairs is 
sustained after birth and what effect this has on neurologic function and timing of 
shunt placement. Moreover, studies may be conducted on the microscopic 
makeup of the patch material (Alloderm) and how this may lead to the 
susceptibility of CSF leakage. Other materials should be studied that may have 
better synergy with the human body to create a more skin-like closure. This may 
lead to a more watertight seal and decrease the chances of the infant developing 
debilitating hydrocephalus and as a result this would reduce the rates of shunt 
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